The nurse practitioner evaluating pediatric patients must integrate knowledge of age-specific pathophysiology with developmental pharmacology and family-centered care principles. Pediatric drug metabolism differs significantly from adults: neonates have immature hepatic cytochrome P450 enzyme systems and reduced renal clearance, while children aged 2-6 years often have enhanced hepatic metabolism requiring higher weight-based doses of certain medications. Common pediatric conditions such as febrile seizures involve age-dependent neuronal excitability due to incomplete myelination and immature gamma-aminobutyric acid (GABA) inhibitory pathways. The clinician must consider growth plate vulnerability when evaluating musculoskeletal injuries, as Salter-Harris fracture classification guides management and prognosis for physeal injuries unique to the pediatric population.